Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Bisphosphonate Treatment
100%
National Register
100%
Renal Function
100%
Real-world Observational Study
100%
CKD Stage
50%
Population-based
33%
DXA Scan
33%
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
33%
Acute Renal Injury
33%
Treatment Options
16%
Kidney Transplantation
16%
Safety Outcomes
16%
Bisphosphonates
16%
Osteoporosis
16%
Alendronate
16%
Biochemical Analysis
16%
Hypocalcemia
16%
Bisphosphonate Use
16%
Prescribers
16%
Medication Possession Ratio
16%
Low Use
16%
Small-gain
16%
Renal Dialysis
16%
Glomerulonephritis
16%
User Groups
16%
User Populations
16%
Estimated Creatinine Clearance
16%
Reduced Kidney Function
16%
National Data
16%
Poor Renal Function
16%
Medicine and Dentistry
Cohort Analysis
100%
Kidney Function
100%
Bisphosphonate
100%
Dual-Energy X-Ray Absorptiometry
44%
Kidney Injury
22%
Kidney Transplantation
11%
Randomized Controlled Trial
11%
Hemodialysis
11%
Osteoporosis
11%
Glomerulonephritis
11%
Hypocalcaemia
11%
Creatinine Clearance
11%
Alendronic Acid
11%
Biochemical Analysis
11%
Treatment Option
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Bisphosphonic Acid Derivative
100%
Kidney Injury
66%
Randomized Controlled Trial
33%
Hemodialysis
33%
Alendronic Acid
33%
Creatinine
33%
Hypocalcaemia
33%
Glomerulonephritis
33%